O2h Discovery

O2h Discovery is a Contract Research Organization (CRO) established in 2005, providing an integrated drug discovery platform. The company operates from research centers located in India and Cambridge, UK, serving the global biotechnology and pharmaceutical sectors. Its core mission is to accelerate drug development through innovative and efficient research services. O2h Discovery leverages its scientific expertise to support clients in advancing their therapeutic pipelines from early-stage research to preclinical development. The company's strategic presence across continents facilitates a broad reach and diverse client engagement.

The organization offers a comprehensive suite of services, including chemistry, biology, and DMPK (Drug Metabolism and Pharmacokinetics). Within chemistry, their capabilities encompass medicinal chemistry, synthetic chemistry, and specialized chemical services, crucial for lead optimization and compound synthesis. The biology division supports target validation and assay development, while DMPK studies assess drug absorption, distribution, metabolism, and excretion. O2h Discovery employs a dedicated team of 500 - 1,000 professionals, fostering a collaborative environment for scientific advancement. Interested parties can learn more about the personnel driving these efforts by visiting Meet O2h Discovery's team. With operations spanning two distinct locations, the company ensures robust service delivery.

Generating approximately $60.0M in revenue, O2h Discovery focuses on delivering high-quality, data-driven results to its business-to-business clientele. Their platform is designed to integrate seamlessly with client workflows, enhancing project timelines and success rates. By combining scientific rigor with a client-centric approach, O2h Discovery aims to be a pivotal partner in the complex journey of drug discovery and development. The company's commitment to innovation is reflectedView more...